Mitul Jadeja works at the Medicines and Healthcare products Regulatory Agency (MHRA) in pharmacovigilance and medicines safety. Having managed teams responsible for adverse drug reactions, Jadeja now leads on Yellow Card Strategy.
Senior medical device specialist Feza Haque and special projects manager Mitul Jadeja explore the importance of Yellow Card reporting